DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Anamorelin
Anamorelin
Effects of the Ghrelin Receptor Agonist Anamorelin
Drug Testing Program
Pharmacological Modulation of Ghrelin to Induce Weight Loss: Successes and Challenges
( 12 ) United States Patent
WO 2010/099522 Al
Growth Hormone Secretagogues: History, Mechanism of Action and Clinical Development
Helsinn Initiates Two New Global Phase III Studies with Anamorelin
Pharmacological Treatments
(12) Patent Application Publication (10) Pub. No.: US 2016/0243197 A1 G00 Sens (43) Pub
2019 Prohibited List
Download Product Insert (PDF)
Stembook 2018.Pdf
Neural Mechanisms of Cancer Cachexia
Structural Basis of Human Ghrelin Receptor Signaling by Ghrelin and the Synthetic Agonist Ibutamoren
Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan
Growth Hormone Secretagogue Receptor
Ghrelin for the Management of Cachexia Associated with Cancer (Protocol)
Anamorelin for Patients with Cancer Cachexia: an Integrated Analysis of Two Phase 2, Randomised, Placebo-Controlled, Double-Blind Trials
Top View
Cancer Cachexia: Medical Management
Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal Muscle Atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model
A Novel Ghrelin Receptor Agonist, for the Treatment of Cancer Anorexia-Cachexia Syndrome: Preclinical Profile
Anti-Doping Convention
Effect of Ghrelin and Anamorelin (ONO-7643), a Selective Ghrelin Receptor Agonist, on Tumor Growth in a Lung Cancer Mouse Xenograft Model
LPGA Prohibited Substances List
Randomised Placebo-Controlled Cross
Banned Substances
55-63. Hophil Min.Fm
2020-USADA-Wallet-Card.Pdf
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
Clinical Significance of Anamorelin Clinical Trials for the Treatment of Cancer Cachexia in Advanced Cancer Patients
Targeting the JAK2/STAT3 Pathway—Can We Compare It to the Two Faces of the God Janus?
Cancer Cachexia and Related Metabolic Dysfunction
In Japanese Patients with Non-Small Cell Lung Cancer and Cachexia: Results of a Randomized Phase 2 Trial
Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation
Efficacy of Anamorelin, a Novel Non-Peptide
Adlumiz, INN-Anamorelin